Form 4: Karyopharm Therapeutics EVP, CFO & Treasurer Michael Mason Sells Shares to Cover Tax Obligations
SEC Form 4
Michael Mason, EVP, CFO & Treasurer of Karyopharm Therapeutics, sold 7,050 shares of common stock at $0.7218 per share to cover withholding tax obligations.
Summary
- On September 4, 2024, Michael Mason, the EVP, CFO & Treasurer of Karyopharm Therapeutics Inc., sold 7,050 shares of the company's common stock.
- The sale was executed at a price of $0.7218 per share.
- The transaction was conducted under a pre-arranged automatic sale plan adopted on June 10, 2021, to cover withholding tax liabilities arising from the vesting of restricted stock units.
- Following the transaction, Mason directly owns 391,054 shares of Karyopharm Therapeutics Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations and doesn't necessarily reflect a change in the executive's outlook on the company.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This sale appears to be related to tax obligations and doesn't necessarily indicate a change in the executive's long-term outlook for the company.
Key Dates
| Date | Description |
|---|---|
| June 10, 2021 | Date the reporting person adopted a durable automatic sale instruction plan |
| 09/04/2024 | Date of the transaction (stock sale) |
| 09/05/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.